Laboratorios Farmaceuticos Rovi, S.A. (BME:ROVI)
Spain · Delayed Price · Currency is EUR 62.10
+0.70 (1.14%)
Oct 27, 2026, 12:00 PM CET
BME:ROVI Stock Forecast
Stock Price Forecast
According to 9 analysts polled by S&P Global, BME:ROVI stock has a consensus rating of "Buy" and an average price target of €73.69. The average 1-year stock price forecast is 18.66% higher than the current stock price, while the lowest is €64.20 (+3.38%) and the highest is €83.00 (+33.66%).
Price Target: €73.69 (+18.66%)
Analyst Consensus: Buy
Price Target
Chart* Price targets were last updated on May 14, 2026.
Analyst Ratings
The average analyst rating for BME:ROVI stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 3 | 3 | 3 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 4 | 4 | 5 | 5 | 5 | 5 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 9 | 9 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Hold Maintains €83.50 → €64.20 | Hold | Maintains | €83.50 → €64.20 | +3.38% | May 14, 2026 |
| Kepler Capital | Kepler Capital | Buy Maintains €90.00 → €83.00 | Buy | Maintains | €90.00 → €83.00 | +33.66% | May 6, 2026 |
Financial Forecast
Revenue This Year
780.35M
from 743.48M
Increased by 4.96%
Revenue Next Year
895.97M
from 780.35M
Increased by 14.82%
EPS This Year
2.90
from 2.75
Increased by 5.56%
EPS Next Year
3.28
from 2.90
Increased by 12.95%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is EUR.